Autopsy report · NCT00670384

Phase 2 Study in Adults Sensitized to Short Ragweed

“No funding.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Antigen Laboratories, Inc.

Sponsor type

Industry

Conditions

Allergic Rhinitis

Interventions

Standardized Allergenic Extract, Short Ragweed (Ambrosia artemisiifolia); Placebo

Participants

0

Trials that died the same way

• Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia
  “No funding at the current time.” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.